Literature DB >> 29208056

Importation, Mitigation, and Genomic Epidemiology of Candida auris at a Large Teaching Hospital.

Emil P Lesho1, Melissa Z Bronstein2, Patrick McGann3, Jason Stam3, Yoon Kwak3, Rosslyn Maybank3, Jodi McNamara4, Megan Callahan4, Jean Campbell5, Mary K Hinkle3, Edward E Walsh6.   

Abstract

OBJECTIVE Candida auris (CA) is an emerging multidrug-resistant pathogen associated with increased mortality. The environment may play a role, but transmission dynamics remain poorly understood. We sought to limit environmental and patient CA contamination following a sustained unsuspected exposure. DESIGN Quasi-experimental observation. SETTING A 528-bed teaching hospital. PATIENTS The index case patient and 17 collocated ward mates. INTERVENTION Immediately after confirmation of CA in the bloodstream and urine of a patient admitted 6 days previously, active surveillance, enhanced transmission-based precautions, environmental cleaning with peracetic acid-hydrogen peroxide and ultraviolet light, and patient relocation were undertaken. Pre-existing agreements and foundational relationships among internal multidisciplinary teams and external partners were leveraged to bolster detection and mitigation efforts and to provide genomic epidemiology. RESULTS Candida auris was isolated from 3 of 132 surface samples on days 8, 9, and 15 of ward occupancy, and from no patient samples (0 of 48). Environmental and patient isolates were genetically identical (4-8 single-nucleotide polymorphisms [SNPs]) and most closely related to the 2013 India CA-6684 strain (~200 SNPs), supporting the epidemiological hypothesis that the source of environmental contamination was the index case patient, who probably acquired the South Asian strain from another New York hospital. All isolates contained a mutation associated with azole resistance (K163R) found in the India 2105 VPCI strain but not in CA-6684. The index patient remained colonized until death. No surfaces were CA-positive 1 month later. CONCLUSION Compared to previous descriptions, CA dissemination was minimal. Immediate access to rapid CA diagnostics facilitates early containment strategies and outbreak investigations. Infect Control Hosp Epidemiol 2018;39:53-57.

Entities:  

Mesh:

Year:  2017        PMID: 29208056     DOI: 10.1017/ice.2017.231

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  11 in total

1.  Inactivation of the multi-drug resistant pathogen Candida auris using ultraviolet germicidal irradiation (UVGI).

Authors:  Angela R Lemons; Tia L McClelland; Stephen B Martin; William G Lindsley; Brett J Green
Journal:  J Hosp Infect       Date:  2020-04-10       Impact factor: 3.926

Review 2.  Healthcare-associated fungal outbreaks: New and uncommon species, New molecular tools for investigation and prevention.

Authors:  Marie-Elisabeth Bougnoux; Sophie Brun; Jean-Ralph Zahar
Journal:  Antimicrob Resist Infect Control       Date:  2018-03-27       Impact factor: 4.887

Review 3.  Barrier Precautions in the Era of Multidrug Pathogens.

Authors:  Rachel Pryor; Carli Viola-Luqa; Olivia Hess; Gonzalo Bearman
Journal:  Curr Treat Options Infect Dis       Date:  2020-06-29

4.  Development of High-Level Echinocandin Resistance in a Patient With Recurrent Candida auris Candidemia Secondary to Chronic Candiduria.

Authors:  Mark J Biagi; Nathan P Wiederhold; Connie Gibas; Brian L Wickes; Victoria Lozano; Susan C Bleasdale; Larry Danziger
Journal:  Open Forum Infect Dis       Date:  2019-06-01       Impact factor: 3.835

Review 5.  Identification of Drug Resistant Candida auris.

Authors:  Milena Kordalewska; David S Perlin
Journal:  Front Microbiol       Date:  2019-08-20       Impact factor: 5.640

Review 6.  Self-disinfecting surfaces and infection control.

Authors:  Micaela Machado Querido; Lívia Aguiar; Paula Neves; Cristiana Costa Pereira; João Paulo Teixeira
Journal:  Colloids Surf B Biointerfaces       Date:  2019-02-16       Impact factor: 5.268

Review 7.  Review on Antifungal Resistance Mechanisms in the Emerging Pathogen Candida auris.

Authors:  Farid Chaabane; Artan Graf; Léonard Jequier; Alix T Coste
Journal:  Front Microbiol       Date:  2019-11-29       Impact factor: 5.640

8.  A cluster-control approach to a coronavirus disease 2019 (COVID-19) outbreak on a stroke ward with infection control considerations for dementia and vascular units.

Authors:  Emil P Lesho; Edward E Walsh; Jennifer Gutowski; Lisa Reno; Donna Newhart; Stephanie Yu; Jonathan Bress; Melissa Z Bronstein
Journal:  Infect Control Hosp Epidemiol       Date:  2021-01-11       Impact factor: 3.254

Review 9.  Candida auris: Epidemiology, Diagnosis, Pathogenesis, Antifungal Susceptibility, and Infection Control Measures to Combat the Spread of Infections in Healthcare Facilities.

Authors:  Suhail Ahmad; Wadha Alfouzan
Journal:  Microorganisms       Date:  2021-04-11

10.  Increasing prevalence, molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait.

Authors:  Ziauddin Khan; Suhail Ahmad; Noura Al-Sweih; Leena Joseph; Wadha Alfouzan; Mohammad Asadzadeh
Journal:  PLoS One       Date:  2018-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.